Merlin L. Robb mainly focuses on Virology, Immunology, Antibody, Virus and Viral load. Her Virology research is multidisciplinary, incorporating elements of Peripheral blood mononuclear cell and Genotype. Her biological study spans a wide range of topics, including HIV vaccine and AIDSVAX.
Her AIDSVAX research is multidisciplinary, relying on both Case-control study and Vaccine efficacy. Her Virus study combines topics from a wide range of disciplines, such as Typing and Polymerase chain reaction. In her study, Internal medicine and Bacterial vaginosis is inextricably linked to Acquired immunodeficiency syndrome, which falls within the broad field of Viral disease.
The scientist’s investigation covers issues in Immunology, Virology, Antibody, Viral load and Immune system. The various areas that Merlin L. Robb examines in her Immunology study include Cytotoxic T cell and HIV vaccine. Many of her studies on Virology involve topics that are commonly interrelated, such as Epitope.
Merlin L. Robb studied Viral load and Internal medicine that intersect with Placebo. Her Vaccination study combines topics in areas such as Immunogenicity and AIDSVAX. Her research integrates issues of Viral Vaccine and Vaccine trial in her study of Vaccine efficacy.
Merlin L. Robb mostly deals with Immunology, Cohort, Viral load, Viremia and Virology. Her research brings together the fields of Ageing and Immunology. Her Cohort study incorporates themes from Transmission, Men who have sex with men, Odds ratio and Cohort study.
The Viral load study combines topics in areas such as Sampling and Statistics. Her work carried out in the field of Virology brings together such families of science as Epitope and Acute HIV infection. Her Immune system research integrates issues from Antibody, Viral rebound, Antiretroviral therapy and Antigen.
Her scientific interests lie mostly in Viremia, Virology, Immunology, Immune system and Vaccination. Her Viremia research incorporates themes from Viral load, Flavivirus, Dengue virus, Chronic infection and Inactivated vaccine. Merlin L. Robb has included themes like Homing and DNA in her Virology study.
Her research on Immunology often connects related areas such as Vaccinia. Her work in the fields of Immune system, such as Vaccine efficacy and Innate immune system, overlaps with other areas such as Monophosphoryl Lipid A. Her work deals with themes such as Regimen, Internal medicine, Placebo, Reactogenicity and Zika virus, which intersect with Vaccination.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm;Punnee Pitisuttithum;Sorachai Nitayaphan;Jaranit Kaewkungwal.
The New England Journal of Medicine (2009)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner.
The New England Journal of Medicine (2012)
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas.
The New England Journal of Medicine (2021)
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies
John R. Mascola;Mark G. Lewis;Gabriela Stiegler;Dawn Harris.
Journal of Virology (1999)
Human skin Langerhans cells are targets of dengue virus infection.
Shuenn-Jue L. Wu;Geraldine Grouard-Vogel;Wellington Sun;John R. Mascola.
Nature Medicine (2000)
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
James B. Whitney;Alison L. Hill;Srisowmya Sanisetty;Pablo Penaloza-MacMaster.
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield.
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Morgane Rolland;Paul T. Edlefsen;Brendan B. Larsen;Sodsai Tovanabutra.
Effect of Human Immunodeficiency Virus Type 1 (HIV-1) Subtype on Disease Progression in Persons from Rakai, Uganda, with Incident HIV-1 Infection
Noah Kiwanuka;Oliver Laeyendecker;Oliver Laeyendecker;Merlin Robb;Godfrey Kigozi.
The Journal of Infectious Diseases (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: